Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-07 08:49 am Purchase | 2025-07-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC | CHING CHOON HWA | 65,359 8.450% | 65,359 (New Position) | Filing History |
| 2025-08-07 08:44 am Purchase | 2025-07-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC | TAN SOO SENG | 69,281 8.950% | 69,281 (New Position) | Filing History |
| 2025-08-07 08:38 am Purchase | 2025-07-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC | TAN CHENG GUAN | 67,974 8.790% | 67,974 (New Position) | Filing History |
| 2025-08-07 08:31 am Purchase | 2025-07-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC | FOONG SOON HONG, RANDY | 70,588 9.120% | 70,588 (New Position) | Filing History |
| 2025-01-21 1:01 pm Sale | 2025-01-17 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Streeterville Capital LLC | 0 0.000% | -338 (Position Closed) | Filing History |
| 2024-10-25 12:19 pm Purchase | 2024-10-25 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Streeterville Capital LLC | 338 9.990% | 338 (New Position) | Filing History |
| 2024-08-15 09:45 am Sale | 2024-08-07 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Forsakringsaktiebolaget Avanza Pension | 0 1.290% | -26 (-99.85%) | Filing History |
| 2024-05-31 10:36 am Purchase | 2024-05-30 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Forsakringsaktiebolaget Avanza Pension | 26 5.420% | 14 (+128.32%) | Filing History |
| 2024-02-09 10:14 am Sale | 2024-02-08 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Forsakringsaktiebolaget Avanza Pension | 11 2.380% | -13 (-53.15%) | Filing History |
| 2024-02-09 06:36 am Purchase | 2024-02-06 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Forsakringsaktiebolaget Avanza Pension | 24 5.070% | 24 (New Position) | Filing History |
| 2023-03-29 2:19 pm Purchase | 2023-03-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Streeterville Capital LLC | 35 9.990% | 35 (New Position) | Filing History |
| 2023-03-29 1:48 pm Sale | 2023-03-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Streeterville Capital LLC | 0 0.000% | -7 (Position Closed) | Filing History |
| 2023-02-13 4:28 pm Unchanged | 2022-12-31 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Lind Global Fund II LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-01-30 4:05 pm Purchase | 2022-10-07 | 13D | China SXT Pharmaceuticals, Inc. SXTC | Zhou Albert Feng | 58 21.498% | 58 (New Position) | Filing History |
| 2022-08-25 3:57 pm Purchase | 2022-08-25 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Streeterville Capital LLC | 7 9.990% | 7 (New Position) | Filing History |
| 2022-01-21 5:01 pm Purchase | 2022-01-20 | 13G | China SXT Pharmaceuticals, Inc. SXTC | Lind Global Fund II LP | 4 9.900% | 4 (New Position) | Filing History |